Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Carie-Care is a chemomechanical caries removal (CMCR) agent used in minimally invasive dentistry to remove dental decay. The primary active ingredient is papain, a proteolytic enzyme derived from the papaya fruit (*Carica papaya*), which selectively dissolves the necrotic, infected dentin by cleaving collagen molecules that have already been partially degraded by the caries process. Because papain lacks the ability to digest healthy, mineralized collagen, the treatment preserves sound tooth structure. The gel also contains clove oil (eugenol), which provides natural analgesic and antimicrobial properties, reducing patient discomfort and bacterial load. This approach minimizes the need for local anesthesia and mechanical drilling, making it particularly suitable for pediatric, geriatric, and phobic patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Carie-Care.